HomeCompareZNZNF vs ORCC

ZNZNF vs ORCC: Dividend Comparison 2026

ZNZNF yields 2.71% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZNZNF wins by $254.98M in total portfolio value
10 years
ZNZNF
ZNZNF
● Live price
2.71%
Share price
$15.31
Annual div
$0.42
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$255.00M
Annual income
$238,135,022.74
Full ZNZNF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — ZNZNF vs ORCC

📍 ZNZNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZNZNFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZNZNF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZNZNF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZNZNF
Annual income on $10K today (after 15% tax)
$230.52/yr
After 10yr DRIP, annual income (after tax)
$202,414,769.33/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, ZNZNF beats the other by $202,414,768.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZNZNF + ORCC for your $10,000?

ZNZNF: 50%ORCC: 50%
100% ORCC50/50100% ZNZNF
Portfolio after 10yr
$127.51M
Annual income
$119,067,511.89/yr
Blended yield
93.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

ZNZNF
No analyst data
Altman Z
7.2
Piotroski
5/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZNZNF buys
0
ORCC buys
18
PoliticianChamberTickerTypeAmountDate
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-23
Trey Hollingsworth🏢 House$ORCC▲ Buy$250,001 - $500,0002022-06-16
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-14
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-13
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-10
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-09
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-06-08
Trey Hollingsworth🏢 House$ORCC▲ Buy$50,001 - $100,0002022-06-03
Trey Hollingsworth🏢 House$ORCC▲ Buy$15,001 - $50,0002022-05-24
Trey Hollingsworth🏢 House$ORCC▲ Buy$100,001 - $250,0002022-05-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZNZNFORCC
Forward yield2.71%9.79%
Annual dividend / share$0.42$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%-50%
Portfolio after 10y$255.00M$21.4K
Annual income after 10y$238,135,022.74$1.04
Total dividends collected$253.73M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ZNZNF vs ORCC ($10,000, DRIP)

YearZNZNF PortfolioZNZNF Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$11,242$542.39$11,190$489.61+$52.00ZNZNF
2$13,169$1,139.77$12,229$256.01+$940.00ZNZNF
3$16,586$2,495.52$13,216$130.74+$3.4KZNZNF
4$23,623$5,874.96$14,207$66.02+$9.4KZNZNF
5$40,916$15,639.51$15,234$33.17+$25.7KZNZNF
6$94,412$50,632.81$16,317$16.62+$78.1KZNZNF
7$319,404$218,383.05$17,468$8.32+$301.9KZNZNF
8$1,722,708$1,380,945.70$18,695$4.16+$1.70MZNZNF
9$15,765,043$13,921,745.00$20,006$2.08+$15.75MZNZNF
10$255,003,619$238,135,022.74$21,407$1.04+$254.98MZNZNF

ZNZNF vs ORCC: Complete Analysis 2026

ZNZNFStock

Zinzino AB (publ), a direct sales company, engages in the sale of nutrition supplements, coffee, coffee machines, and accessories; The company offers balance control, immunity control, weight control, and skin care products. It also provides espresso machines, coffee, tea, and accessories. The company markets and sells its products in Sweden, Norway, Denmark, Finland, Iceland, Estonia, Lithuania, Latvia, Germany, Austria, Switzerland, the Netherlands, Poland, Hungary, Romania, Spain, Cyprus, France, Greece, Italy, United Kingdom, Czech Republic, Slovakia, the United States, Canada, Singapore, Malaysia, Taiwan, Thailand, Hong Kong, Australia, South Africa, and India. Zinzino AB (publ) was founded in 2005 and is headquartered in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia, and India.

Full ZNZNF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this ZNZNF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZNZNF vs SCHDZNZNF vs JEPIZNZNF vs OZNZNF vs KOZNZNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.